The BioLymph study - implementing precision medicine approaches in lymphoma diagnostics, treatment and follow-up: feasibility and first results
Acta Oncol
.
2023 Jun;62(6):560-564.
doi: 10.1080/0284186X.2023.2218556.
Epub 2023 Jul 6.
Authors
K E Smedby
1
2
,
T Wästerlid
1
2
,
E Tham
3
4
,
Z Haider
3
,
J Joelsson
1
2
,
B Thorvaldsdottir
3
,
A Krstic
4
,
B E Wahlin
1
5
,
H Foroughi-Asl
,
C Karlsson
1
6
,
S Eloranta
2
,
L Saft
6
,
M Palma
1
6
,
A Kwiecinska
7
,
L Hansson
1
6
,
A Österborg
1
6
,
V Wirta
8
9
10
,
G Rassidakis
6
7
,
B Sander
7
11
,
K Sonnevi
1
5
,
R Rosenquist
3
4
10
Affiliations
1
Dept of Hematology, Karolinska University Hospital Solna, Sweden.
2
Dept of Medicine Solna, div of Clinical Epidemiology, Karolinska Institutet, Stockholm, Sweden.
3
Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
4
Dept of Clinical Genetics, Karolinska University Hospital Solna, Stockholm, Sweden.
5
Dept of Medicine Huddinge, Karolinska Institutet.
6
Dept of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
7
Dept of Clinical Pathology and Cancer Diagnostics, Karolinska University Laboratory, Solna and Huddinge, Sweden.
8
Science for Life Laboratory, Dept of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
9
Science for Life Laboratory, Royal Insititute of Technology, Stockholm, Sweden.
10
Genomic Medicine Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.
11
Dept of Laboratory Medicine, Karolinska Institutet Stockholm, Sweden.
PMID:
37415362
DOI:
10.1080/0284186X.2023.2218556
No abstract available
MeSH terms
Feasibility Studies
Humans
Lymphoma* / diagnosis
Lymphoma* / genetics
Lymphoma* / therapy
Precision Medicine* / methods